Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-2,780 Cr₹77 Cr₹-1,781 Cr₹-1,651 Cr₹-1,549 Cr

What is the latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of TORRENT PHARMACEUTICALS is ₹-2,780 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-2,780 Cr
Mar2023₹77 Cr
Mar2022₹-1,781 Cr
Mar2021₹-1,651 Cr
Mar2020₹-1,549 Cr

How is Cash Flow from Financing Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-2,780 Cr
Negative
Mar2023 ₹77 Cr
Positive
Mar2022 ₹-1,781 Cr
Negative
Mar2021 ₹-1,651 Cr
Negative
Mar2020 ₹-1,549 Cr -

Compare Cash Flow from Financing Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹108,462.3 Cr -3.3% -5.7% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-3.3%

-5.7%

28.7%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses